Wednesday 27 August 2014

Continuous Glucose Monitoring Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019

Continuous Glucose Monitoring SystemAccording to a new market report published by Transparency Market Research "Continuous Glucose Monitoring Market (Guardian Real Time, FreeStyle Navigator, Dexcom Seven Plus, Dexcom G4 Platinum, MiniMed Paradigm Revel/Veo CGM Systems and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019," the global continuous glucose monitoring market was valued at USD 0.37 billion in 2012 and is expected to grow at a CAGR of 13.6% from 2013 to 2019, to reach an estimated value of USD 0.91 billion in 2019.

Browse the Continuous Glucose Monitoring Market Report with Full TOC at http://www.transparencymarketresearch.com/continuous-glucose-monitoring.html

Continuous glucose monitoring systems (CGMS) are real time glucose monitoring devices that measure and display the glucose level of the interstitial fluid in the skin cells of the patient. These devices help patients manage diabetes (Type 1 and Type 2) in a more efficient manner. CGM devices typically comprise a sensor, transmitter and a receiver. The sensor is placed underneath the skin for monitoring glucose levels and is attached to the transmitter that relays the information to the monitor. Until recently, management of diabetes involved the use of conventional blood glucose meters that provided a single time snapshot of the patient's blood glucose level. However, demand for real time monitoring, minimally invasive and effective diabetes management solutions led to the advent of CGM devices. Rise in the incidence of diabetes globally coupled with increasing awareness of such devices that possess the ability to detect hyper and hypoglycemic events in real time will fuel the growth of this market during the forecast period.


CGM is a rapidly evolving market supported by increasing adoption of these systems by hospitals and individual practitioners who further encourage their patients to use these devices. However, CGM systems are not meant to be replaced by the traditional diabetes management devices. Hence, the technology still requires innovation in terms of accuracy and precision. Reimbursement issues, high cost of devices and low market penetration rates are some of the factors that are expected to hinder market growth in the near future. Medtronic's Guardian Real Time CGM System accounted for the largest share of the global marketin 2012, accounting for a share of over 40%. The product's first mover advantage in the market, proper positioning and marketing of the product, and ease of convenience and usability helped it achieve this leadership position. Dexcom's fourth generation product, namely, Dexcom G4 Platinum is anticipated to witness the highest market growth at a CAGR of 22.6% during the forecast period. G4 Platinum is the most recently launched device (2012) and is the most technologically advanced, offering more accuracy and reliability as compared to other commercially available devices. In addition, integration of this device with insulin pumps from various other manufacturers like Johnson & Johnson and Tandem Diabetes Care would also drive the growth of this market segment.

Browse all Medical Devices Market Research Reports @ http://www.transparencymarketresearch.com/medical-devices-market-reports-6.html

Geographically, North America captured majority share of the global continuous glucose monitoring market in 2012. Increase in type I diabetic population along with rise in geriatric population which will in turn spur the demand for regular monitoring of glucose levels will fuel the growth of this market. Major players of this market are domiciled in this region, which allows easy market penetration and will also contribute towards market growth. The European CGM market is in a rapidly evolving state and contributed the largest share of the total CGM market revenue in 2012. Asia-Pacific is expected to witness tremendous increase its market share and emerge as the fastest growing region, reporting a CAGR of 16.9% during the forecast period. Economic developments, presence of a large patient pool, rising patient awareness, increasing disposable income and changing lifestyle are some of the significant factors that are poised to increase the demand for CGM systems in this region.
Key players in this market include Medtronic, Inc., Dexcom, Inc. and Abbott Diabetes Care. Medtronic was the leading player of this market in 2012, accounting for a share of over 50%. Abbott saw a decline in its market share due to withdrawal of Free Style Navigator from the U.S. market in the fourth quarter of 2011. However, the expected launch of Free Style Navigator ll in 2014 in the U.S. market would help the company restore its market position. Other companies such as Johnson & Johnson, Bayer Healthcare and Tandem Diabetes Care are adopting the strategy of partnerships and collaboration to enter this dynamic market.

Endoscopy Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019

Endoscopy Devices Market
Global Endoscopy Devices Market
According to a new market report published by Transparency Market Research "Endoscopy Devices Market (Endoscopes, Endoscopic Operative Devices, and Visualization Systems) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013-2019" the global endoscopy devices market was valued at USD 24.9 billion in 2012 and is expected to grow at a CAGR of 6.8% from 2013 to 2019, to reach an estimated value of USD 36.9 billion in 2019.

Browse the full Endoscopy Devices Market Report with TOC at http://www.transparencymarketresearch.com/endoscopy-devices-market.html

Endoscopy procedures are performed by inserting rod shaped telescope and specialized instruments through small incisions in the body. These procedures can be diagnostic as well as operative, and are explored for various areas of surgery including gastrointestinal, urological, ENT, cardiovascular and joint surgeries. As these are minimally invasive procedures, they provide various advantages over open surgeries such as reduced blood loss, reduced chances of infection, shorter hospital stay, and quick recovery. Due to these advantages, the adoption of endoscopy is increasing rapidly; especially in the field of oncology.
An endoscopy system comprises of an endoscope, visualization system (which includes the camera, control unit, illumination devices, image processing devices, and display) and various specialized operative instruments (which include energy systems, internal closure devices, irrigation systems, and others). An endoscope that is rigid, finds applications in arthroscopy and laparoscopies and flexible endoscopes have application in gastrointestinal, urology and other systems where rigid endoscope may not reach. Modern endoscopes called as videoscopes have a "chip-on-tip" which deliver better image quality and are more durable. Fiberoptic endoscopes are fragile and delicate, hence get damaged easily. This is a major driver for videoscopes market and the technology is expected to replace fiberoptic and rod-lens systems in the near future. Consistent technological advances have added new products to the market and expanded boundaries of the endoscopy devices market. Capsule endoscopes and robot assisted endoscopes have revolutionized the endoscopy market.


The capsule shaped devices possess built-in camera unit and wireless transmission system which delivers high quality images to external receiver as they pass through the gastrointestinal tract. The device has made diagnosis of gastrointestinal tract more efficient as the capsule is able to deliver images for intestinal areas where flexible endoscope cannot reach. Given Imaging (acquired by Covidien) accounts for about 85% of the global capsule endoscopy market share. Other key players in the capsule endoscopy market include Olympus, IntroMedic and Jinshan Medical. Intuitive Surgical leads the robot assisted endoscopy market with its flagship Da Vinci surgical system. Other companies making their mark in the robot assisted endoscopy market include Endo Control, Inc., Olympus, Meere Company, Inc., MAKO Surgical and Titan Medical, Inc. Visualization systems have been a prominent area of technological advancements.


The development of chromoendoscopy has added another dimension to the evolving market of endoscopy. Three dimensional (3D) camera systems have improved the depth perception and hence reduced errors during surgery and which has further reduced the overall surgery time. Endoscopic ultrasound devices now allow doctors to effectively diagnose intestinal tract, which might be difficult to diagnose otherwise with traditional ultrasound devices. As the ultrasound device is close to the organ as, the images obtained are more accurate giving better examination of the intestinal tract.
Although various merits are propelling the endoscopy devices market, some factors impede the acceptance of several endoscopic devices. Prominent among these factors is the high cost of latest technology devices, which has delayed the penetration of these products in developing countries. Lack of skilled professionals is also a major concern for the market to develop. Considering various market dynamics, companies are eying Asian countries which mainly include India, China, and Japan for lucrative opportunities in future. Rapidly developing economic condition, improving healthcare sector, available disposable income, and large consumer base in emerging economies such as India, China, Brazil and South-East Asia due to high prevalence of diseases will drive the endoscopy devices market in these countries.

Surgical Navigation Systems Market Expected to Reach USD 295.5 Million Globally in 2020: Transparency Market Research

Surgical Navigation Systems Market
Surgical Navigation Systems Market
According to a new market report published by Transparency Market Research "Surgical Navigation Systems Market (Neurosurgical Navigation Systems, ENT Navigation Systems and Orthopedic Navigation Systems) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020", the global surgical navigation systems market was valued at USD 218.5 million in 2013 and is expected to grow at a CAGR of 4.5% from 2014 to 2020, to reach an estimated value of USD 295.5 million in 2020.

Browse the full Surgical Navigation Systems Market Report: http://www.transparencymarketresearch.com/surgical-navigation-systems-market.html

Surgical navigation systems assist surgeons in reaching the target anatomical position of the patient. Post-operative wound healing takes more time in conventional surgeries than minimally invasive surgeries due to smaller incision. Surgical navigation systems enable minimally invasive surgeries. In addition, surgical navigation systems facilitate reaching precise targeted anatomical site for surgery, more accurate operative procedure and thereby decreasing risk of failure. Thus, adapting surgical navigation systems in practice is beneficial for both patients as well as hospitals. Therefore, market players are implementing various strategies to spread awareness about surgical navigation systems and related benefits which is ultimately resulting in growth of the global surgical navigation systems market.

The global surgical navigation systems market is segmented on the basis of type of products namely, neurosurgical navigation systems, ENT navigation systems and orthopedic navigation systems. Neurosurgeries including spinal surgeries are the most complicated surgeries and thus demand for accuracy is higher in neurosurgeries. Hence, neurosurgical navigation systems accounted for the largest market share in 2013.


High cost of surgical navigation systems is one of the major factor that is restraining the growth of the global surgical navigation systems market. Demand for surgical navigation systems is expected to rise with increased awareness about surgical navigation systems and related benefits. Further, to expand market share, existing players in the surgical navigation systems market are expected to implement strategies such as acquisition of small players, partnering with the competitor and offering long-term contracts to customers in order to maintain relation with end users.


Presently, North America is dominating the global surgical navigation systems market with a share of 40% in 2013. Some of the major factors that are driving the North American surgical navigation systems market towards growth include well-defined regulatory framework, higher rates of implementing regulations in practice that are set by regulatory authorities and highly developed healthcare infrastructure. The Asia-Pacific region is anticipated to have higher growth potential for surgical navigation systems market due to rapidly developing healthcare infrastructure on the grounds of swiftly rising medical tourism industry in the region. Some of the key market players contributing to surgical navigation systems industry include BrainLAB AG, Aesculap Implant Systems (B. Braun Melsungen AG), LLC, GE Healthcare, Medtronic, Inc., Siemens Healthcare Corporation, Stryker Corporation and Zimmer Holdings.

Geriatric Care Services Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019

Geriatric Care Services
Geriatric Care Services
According to a new market report published by Transparency Market Research "Geriatric Care Services Market (Home Care, Adult Day Care, and Institutional Care) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019," the global geriatric care services market was valued at USD 560.4 billion in 2012 and is expected to grow at a CAGR of 5.9 % from 2013 to 2019, to reach an estimated value of USD 850.0 billion by 2019.
The rising population of baby boomers in the U.S. is a major factor driving the global geriatric care services market wherein a new study shows that the demand outstrips the supply of these services across the globe. There are service providers as small as a family forming a home care agency to few large companies with national and even international operations which implies that the market is underserved and is also highly fragmented.

Browse the full Geriatric Care Services Market Report with TOC at http://www.transparencymarketresearch.com/geriatric-care-services-market.html

The developed nations have anticipated the situation and are putting efforts to reduce the imbalance by increasing private service providers in the sector. However, most countries in the Asia-Pacific are far away from the thought of private senior care sector and have a stigma associated with senior care being provided by people other than the family members, friends and relatives. The scenario of senior care in these countries is however changing with time and creating new space and opportunities for the market.

The global geriatric care services market is analyzed by the type of services, and geography. On the basis of type of services, the market has been segmented into home care, adult day care and institutional care. The major geriatric population receives care from informal caregivers such as close family members which may include spouse, children, grandchildren, friends and relatives. The need for formal care arises when informal care is unavailable and is provided either in one or more forms of services mentioned earlier. The choice of these services depends on the need of care receiver senior adult and the ability to pay for these services. In 2012, the institutional care segment accounted for the largest market share in the global geriatrics market, followed by rapidly growing home care segment.


Institutional care is the costliest among all the care services available but provides high level of care and has been the most developed and largest segment. However, high cost and the feeling of abandonment by family sensed by the elderly are limiting the growth of this segment. While speaking on this issue, Bunni Dybnis, an elder care industry veteran states the reason - "there are many people who would benefit from elderly care service, but a relatively few actually have paid or other non-related caregivers. Most are relying on family and other informal assistance. Cost, affordability, frugality, cultural traditions and resistance are all factors. Affordability is a major issue, but only one of many."
The restraints for institutional care settings are favoring the growth of other market segments. The community care in the form of adult day care is also a growing segment which is supplementing the role of home care services by providing respite to the home care geriatric care workers. Tracey L. Wolfman, Adjunct Professor at Monmouth University, and a CEO of We Care Adult Care Inc., justifies the growth of Adult Day Care Services. In her opinion "Adult Day Care allows individuals to receive comprehensive quality care at half the price of home care, or one-fourth the cost of assisted living or nursing homes. A person can attend Adult Day Care during the day and return to their home at night". Adult day care services offer several advantages such as living at home, skilled nursing care, enhanced quality of life, recreation, social interaction and respite to caregivers which contributes to the growth of the market.

Browse All Medical Devices Market Research Reports @ http://www.transparencymarketresearch.com/medical-devices-market-reports-6.html

North America and Europe are expected to maintain their leading positions in the global geriatric care services market throughout the forecast period from 2013 to 2019. In developed nations such as the United States, Canada, Germany, France, the U.K., Italy and Spain, the market is witnessing high growth due to increasing number of aged people opting for geriatric care services. The chronic illness among elderly people, increased life expectancy, and the limitations in performing cognitive and functional activities (i.e. activities of daily living) are the evident reasons for the growth of geriatric care services market in developed nations. The rising pressure on hospitals to reduce stay of patients is contributing to the growth of the out of hospital care services. Many countries in these regions have presence of several large companies and independent service providers which fulfill the needs of geriatrics care.
Geriatric care services market in these regions is trending towards consolidation while on the other hand the market in Asia-Pacific and Rest of the World regions is highly underdeveloped. Brookdale Senior Living, Inc., Extendicare, Inc., Genesis HealthCare Corp., Gentiva Health Services, Inc., GGNSC Holdings, Home Instead Senior Care, Inc., Kindred Healthcare, Inc., Senior Care Centers of America, Skilled Healthcare Group, Inc., and Sunrise Senior Living, Inc. are some of the major companies operating in the global geriatric care services market.

Tuesday 26 August 2014

Global Magnetic Resonance Imaging (MRI) Market Worth US$ 4.8 billion by 2017: Transparency Market Research

Magnetic Resonance Imaging (MRI) Market
Magnetic Resonance Imaging (MRI) Market
A study on the global magnetic resonance imaging (MRI) market has been recently added to Transparency Market Research’s database of market reports. Titled “Magnetic Resonance Imaging (MRI) Market: Global Market Analysis, Size, Share & Forecast (2011 - 2017)”, the report indicates that the global MRI market, which valued US$ 3.9 billion in 2011, would observe growth at a CAGR of 3.5% from 2011 to 2017(the forecast period of the report), and end-up valuing US$ 4.8 billion by 2017.
Amongst the various regional market segments of the global magnetic resonance imaging (MRI) market, the region of America is expected conquer nearly 37.3% shares of total global revenues by the end of 2017. Revenue shares of Asia-Pacific are expected to closely follow those of America during this time.

Browse Magnetic Resonance Imaging Market Research Report with complete TOC http://www.transparencymarketresearch.com/magnetic-resonance-imaging-market.html

The report segments the market of MRI equipments on three bases: Categories of MRI equipments according to their structure, categories of MRI equipment according to Magnetic Field Strength, and the major regional markets.
Based on their structure, the magnetic resonance imaging (MRI) equipment market is further categorized as Open MRI and Closed MRI devices. Based on the magnetic field strength of the devices, the market is further categorized as Low-Field, Mid-Field and High-Field devices. The major geographic segments of the market include Americas (North and South America), Europe, Asia-Pacific and the Rest of the world.


According to the report, the major reasons behind the swift growth of the global magnetic resonance imaging (MRI) market include a significant rise in world’s ageing population, which is estimated to cross 970 million by 2030, and the overall rise in patients with chronic diseases such as diabetes, breast cancer and a variety of heart diseases. MRI aids in the early diagnostics of diseases by virtue of detailed images of human anatomy. The easing economic situations, a constant rise in disposable incomes and the rising awareness about the benefits of early diagnosis in economically developing regions of the world are leading this market towards positive growth.
The market segments of open and closed MRI devices are expected to observe growth at a CAGR of 4.8% and 2.5% respectively during the forecast period of the report.


In the field-strength wise categorization, the segment of low field magnetic resonance imaging (MRI) is expected to observe a decline of nearly 9% during the forecast period. This would bring the market value of this segment down to US$ 282.4 million in 2017.
Geography-wise, the regions of Americas and Europe currently generate the major chunk of revenues for the entire global market. During the forecast period, however, market in the regional segment of Asia-Pacific is expected to observe growth at the fastest pace. The rising levels of awareness about benefits of early diagnosis and affordability of advanced healthcare services due to the rising economic stability of the population are the chief reasons behind this.
Americas currently lead the market in terms of revenues generated from the segment of Open MRI devices. During the forecast period too, this region is expected to acquire nearly 37.3% shares of the total global market of this product category due to the high levels of awareness, rising percentage of ageing population, and rising prevalence of chronic diseases in this region.

Global Home Healthcare Market to Reach US$305.9 billion by 2018: Transparency Market Research

Home Healthcare Market
Home Healthcare Market
A research report based on the global home healthcare market has been recently added to the comprehensive market-research database of Transparency Market Research. The report, titled “Home Healthcare Market - Global Industry Size, Market Share, Trends, Analysis and Forecast, 2012 – 2018”, states that the global home healthcare market, which stood at US$195.6 billion in 2012, would see a CAGR of 7.7% from 2012 to 2018, and be worth US$305.9 billion by 2018.

Browse Home Healthcare Market Research Report at http://www.transparencymarketresearch.com/home-healthcare-market.html

The report focuses on three broad sections of the market – home healthcare equipment, home healthcare services, and popular geographic markets. The segment of equipment is further segmented into self-diagnostic and monitoring, therapeutic, nebulizer kits, ventilators and accessories, and mobility assistance devices. The segment of services is further segmented into rehabilitation, unskilled, respiratory therapy, infusion therapy, telemetry/telehealth, vital sign monitoring, multi-parameter monitoring and central station services. Geographically, the market is segmented into Americas (North and South America), Europe, Asia-Pacific, and the rest of the world.
According to the report, the major factors contributing to the growth of the global home healthcare market include the significant rise in the global ageing population - set to cross 970 million by 2030, and the increasing number of people experiencing chronic diseases such as a variety of respiratory diseases, asthma, high blood pressure, and diabetes, thus requiring long-term treatment.


The high prevalence and rising incidences of such chronic diseases also requires an increasingly improved mechanism for close and regular monitoring of patients, for which home healthcare systems prove to be ideal. These systems do not only serve the purpose of regular patient monitoring, but are also reliable and cost efficient.
According to the report, high level of consumer awareness about the benefits of these products and high adoption rates in North and South America will allow the market to achieve significant market proliferation in these regions. This will help these regions to collectively contribute the global home healthcare market revenues worth US$ 150.8 billion by 2018. The market in Europe is expected to have market value worth US$ 80.5 billion by the same time.


Currently, the global share of the equipments section of this market is less as compared to that of the services segment. But the report mentions that this segment has the potential of growing at a faster pace, an estimated 9.9% CAGR, during the forecast period owing to the rise in technological innovation, especially in the therapeutic equipment segment.
Though the segment of home healthcare services occupies a big market-share of this market, it may observe growth at a sluggish pace, an expected CAGR of 7.4% during the forecast period. This is due to the large number of regional service providers in the market who are offering services at low prices and are deterring the entry of organized players in the market. Also, a sizeable chunk, nearly 79.9%, of the global services market is acquired by rehabilitation and unskilled care service providers. Owing to these factors, big players of the market have shifted their attention towards the home equipments market segment. Contrast to the services segment that is highly fragmented, and conquered by small and unorganized businesses, the equipments section is dominated by a few major companies such as Johnson and Johnson, GE Healthcare, Philips Healthcare, Braun, Baxter International, Medtronic Inc., Invacare Corporation and Omron Corporation.

Global Spectrometry Market to be Worth US$19,608.7 million by 2020: Transparency Market Research

Spectrometry Devices Market
Spectrometry Devices Market
A research report based on the global spectrometry market has been recently published by Transparency Market Research. The report, titled “Spectrometry Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020”, states that the global spectrometry market, which valued US$ 12,212.9 million in 2013, would see a CAGR of 7.2% from 2014 to 2020, by which year it would be worth US$19,608.7 million.
According to the report, the major growth driver behind the rising popularity of the global spectrometry market is the high rate of influx of increasingly innovative products in the market. Technological innovations in the field of spectrometry have allowed the global spectrometry market in catering to a vast array of applications from a variety of industries. Especially, the entry of handheld and portable spectrometry devices in the market has led to an added demand from the drug identification, defense, food inspection and environmental protection sectors.

Browse Spectrometry Market Research Report with complete TOC at http://www.transparencymarketresearch.com/spectrometry-market.html

The report focuses on three major segments of the market – technologies, applications, and major regional markets on the global front.
Technology-wise, the market is further segmented into mass spectrometry, molecular spectrometry and atomic spectrometry. Amongst the various sub segments of these major segments, revenues of nuclear magnetic resonance spectrometry – a sub-segment of molecular spectrometry is likely to lead the global spectrometry market by amassing a market value worth US$ 1.7 billion by the end of 2020.
Sales in the overall molecular spectrometry segment are also expected to achieve substantial growth owing to the increasing demand for infrared, near-infrared and Raman spectrometry devices in security and defense, research and academic sectors.


Amongst the major end-user applications, the sectors of life sciences, food and beverages testing, biotechnology, environmental testing and industrial chemistry are discussed in-depth in the report. Rising applications of spectrometry devices in clinical tests such as tissue analysis, proteomics, disease marking and toxicology has significantly contributed towards the growth and global uptake of the spectrometry market.
Stringent regulations surrounding the fields of soil and water testing are also substantially contributing positive growth of this market on a global front. By 2020, the application segment of biotechnology is expected to observe growth at a CAGR of 18.4%, making it the fastest growing application segment of the market during the report’s forecast period.

Browse more Medical Devices Related Research Reports at http://www.transparencymarketresearch.com/medical-devices-market-reports-6.html

Geographically, the report segments the spectrometry market into four prominent regional markets – North America, Asia-Pacific, Europe and the Rest of the World. The report states that the market has attained a saturation level in developed economic countries such as Europe and the US, but the array of breadth of application areas has also widened. Rising demands from these relatively new application areas such as space, aeronautics and defense in these regions would continue to drive the market.
However, regional market of Asia-Pacific and the Rest of the World will be the fastest growing markets throughout the forecast period. Key players are keen on investing in these regions due to a huge customer base and rising research related activities in countries like China, India and some other countries in the South-East Asian region.
The global spectrometry market experiences intense competition; large companies are competing for relatively smaller application areas and product segments. Major shares of revenues are held by multinational companies including Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., Shimadzu Corporation, AB Sciex, Perkin Elmer, Inc., and Waters Corporation.

Computed Tomography (CT) Market Global Industry Analysis, Size, Share & Forecast (2010 – 2017)

Computed Tomography (CT) Market
Computed Tomography (CT) Market
A new research report, titled “Computed Tomography (CT) Market: Global Industry Analysis, Size, Share & Forecast (2010 – 2017)”, has been recently added to the vast research-report repository of Transparency Market Research. The report provides comprehensive market data about shares and sizes of various market elements, along with in-depth insights about past and current trends, opportunities, threats, and a wealth of other market data on the global computed tomography market.
According to the report, the global computed tomography (CT) market is expected to grow from US$4.3 billion in 2011 to US$5.6 billion in 2017, observing growth at an estimated CAGR of 4.5% during 2011 to 2017, the forecast period of the report.

Browse Computed Tomography Market Research Report with complete TOC http://www.transparencymarketresearch.com/computed-tomography-market.html

The report states that the major reasons behind the current growth and future prospects of this market are the rising share of ageing people in the world’s population and an overall rise in patients with chronic diseases throughout the globe. The effect of ageing of a major part of the world’s population is more profoundly evident in the Asia Pacific region.
This report focuses on two segments of the global computed tomography (CT) market – product types and popular markets based on geographic segmentation. Product-type wise, the market is further segmented as low end slice computed tomography (CT), mid end slice computed tomography, and high end slice computed tomography.


Amongst these segments, the segment of high end slice CT is expected to amass the major chunk of revenues of the global CT market, an estimated 55.9%, and end-up valuing nearly US$3.1 billion by the year 2017.
Amongst the various geographic segments of the global CT market, Americas (North and South America) is expected to acquire nearly 37.4% shares of the global CT market and maintain its lead position in 2017, followed by Asia. Europe stands as the second largest market leader of the global CT market.

Browse Medical Devices Related Research Reports at http://www.transparencymarketresearch.com/medical-devices-market-reports-6.html

The geographic region of Americas currently also leads in the high-end CT product segment. The chief reasons behind the popularity of this product-type in this region include the huge technological developments and health conscious ageing population.
During the forecast period, growth in the Asia-Pacific region is expected to outpace growth for the CT industry in other major geographic sections, majorly due to the rising awareness, increased financial stability and emerging numbers of healthcare centers in this region.
The rise in disposable incomes and the increase in awareness about early diagnosis of chronic diseases in other developing countries as well is a major factor behind the growth of the global CT market. What is adding fuel to the growth is the declining cost of devices and increasing accuracy with the continuous technological developments in the CT industry.

Monday 25 August 2014

Cervical Cancer Diagnostic Tests Market is Expected to Reach USD 75.2 Million Globally in 2018: Transparency Market Research

 Cervical Cancer Diagnostic Tests MarketAccording to a new market report published by Transparency Market Research , "Cervical Cancer Diagnostic Tests (Pap Smear, Colposcopy and ECC Procedures) Market - Global Industry Analysis by Test Type and Age Group, Market Size, Share and Forecast, 2012 - 2018," the global Pap smear test market was valued at USD 28.0 million in 2011 and is expected to reach an estimated value of USD 31.4 million in 2018, growing at a CAGR of 1.7% from 2012 to 2018. The global edocervical curettage (ECC) procedures market was valued at USD 6.7 million in 2011 and is the fastest growing segment owing to its accuracy during cervical cancer diagnosis.

Browse the Cervical Diagnostic Tests Market report with complete TOC: http://www.transparencymarketresearch.com/cervical-cancer-diagnostic-tests-market.html

A high prevalence of HPV-infected patients across the globe, rising incidences of teenage sexual encounters, a rising number of organized cervical cancer programs initiated by governments and NGOs and the rising disposable income of consumers especially in the Asia Pacific region are some of the major growth drivers for the Pap smear tests market. An increasing number of female smokers worldwide and the rising world obesity rate also support the growth of the market.
Government regulations extending the age limit for a Pap smear test in an attempt to curb unnecessary healthcare-related expenditure will restrain the growth of the market to a certain extent. The future of the Pap smear tests market will be fuelled by technological advancements such as the invention of new cytological methods of testing and the rapidly aging population in the U.S., Europe and Japan.


The cervical cancer diagnostic tests market is dominated by the U.S. which holds a market share of around 31.3%. In Europe, Germany is the market leader in terms of revenue generated through Pap smear testing. The Asia Pacific market is expected to exhibit the fastest growth rate during the forecasted period (2012 - 2018). India and China together form the most lucrative segment of the Asia Pacific region owing to their fast growing population coupled with high disposable incomes amongst consumers and high healthcare-related spending induced by the rapidly developing nature of their economies.
Some of the key players profiled in the report include Guided Therapeutics, Abbott Laboratories, Siemens Healthcare, Ascon Medical Instruments, Olympus, Beckman Coulter Inc, Roche, Cooper Surgical Inc, Cardinal Health and Becton and Dickinson and Company.


This research is specially designed to estimate and analyze the demand and performance of the cervical cancer diagnostic tests market taking into consideration Pap smear tests, ECC procedures and Colposcopy procedures in a global scenario. The report also provides the number of procedures performed, broken down by age group for each segment of the market. The report covers the market by test steps for cervical cancer diagnostic purpose.

Interventional Cardiology Devices Market - Global Industry Size, Market Share, Trends, Analysis And Forecast 2012 – 2018

Interventional Cardiology market
Interventional Cardiology market
Interventional cardiology techniques refer to nonsurgical methods for diagnosing and treating narrowed blood vessels in heart, neck abdomen and legs by inserting tube-like devices (catheters) into the blood vessels through minute incisions in the groin. These techniques are minimally invasive and serve as alternatives to open heart surgeries in a variety of cases. The market is segmented in three major product types namely stents, Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons and PTCA guidewires. Catheters and balloon inflation devices fall under the product segment PTCA guidewires.

Browse Interventional Cardiology Devices Market Research Reports with complete TOC at http://www.transparencymarketresearch.com/interventional-cardiology-devices.html

Amongst these major product types, the market of stents currently garners the major shares for the overall interventional cardiology devices market. This market segment is also the fastest growing segment of the market, owing majorly to the advent of products such as bio-degradable and drug eluting stents. The introduction of scoring balloons in the PCTA balloons section could also lead to rapid growth of the PCTA balloons segment of the market in near future.The major driving factors of this market are the rising incidences of cardiovascular diseases on a global front, rising population of age-old people, rising awareness about the benefits of interventional cardiology techniques and the increasing population of specialists in this industry across the globe.


Rapid technological developments that strive to make the basic techniques even more fruitful, such as the discovery of bio-absorbable and drug eluting stents that reduce the rate of re-stenosis and stent thrombosis, have also the market in growing substantially over the years. With devices like this, the procedures are becoming increasingly complication free and consequently more popular.
The market is flourishing due to the general shift in preferences of practitioners based on their ease of use and the decline in complications post procedure. Such shift is especially evident in stents, where the industry has especially worked hard and produced many sophisticated techniques with every new product invention. From the inception with metal stents to the latest bio-absorbable stents, the company has come very far.

Browse Medical Devices Related Research Reports at http://www.transparencymarketresearch.com/medical-devices-market-reports-6.html

The market of North America is currently the leader in the global interventional cardiology devices market. This is majorly due to the developed economies of the U.S. and Canada. The high awareness among the general population about the benefits of these techniques are the major reasons behind the growth of these geographic segments. Asia, as for many other industries, represents one of the major markets for this industry in the near future. The huge base of population in Asian countries such as China and India, a large share of which is getting old, is the major reason behind the enormous growth potential provided by this region for global interventional cardiology devices market.


Ophthalmic Drugs Market is Expected to Reach USD 21.6 Billion Globally in 2018

Ophthalmic Drugs Market
Ophthalmic Drugs Market
The popularity of prescription drugs in ophthalmology needs no specific mention – they are quite easily the more popular medications for majority of ocular conditions. But it is the segment of over-the-counter ophthalmic medicines for ocular conditions such as infections and dry eye that are often the first medicines that a patient uses. According to market analysts, the global ophthalmic drugs market will grow from USD 16 billion in 2012 to USD 21.6 billion in 2018, observing growth at an average CAGR of 5.2% during the next 4-5 years.
The global ophthalmic drugs market is driven by key factors such as rising prevalence of ocular disorders such as diabetic retinopathy, macular degeneration, largely affected by the rising percentage of ageing population in the world, and a rising occurrences of lifestyle related issues such as dry-eye disease.

Browse Full Ophthalmic Drugs Market Research Report With Complete TOC @ http://www.transparencymarketresearch.com/ophthalmic-drugs-market.html

The rising initiatives from government for improvement of healthcare facilities, especially in the developing economies such as China and India and the technical development in drug delivery techniques are also some reasons that are driving the global ophthalmic drugs market.
However, the market also has its own set of problems that may have a negative impact on its growth, namely the lack of awareness amongst the population about the benefits of early diagnosis, the lack of new formulations in the market, and patent expiry of some major drugs in the market.


Global Ophthalmic Drugs Market – Segmentation
For the ease of understanding, the global market of ophthalmic drugs can be generally segmented in three major divisions – drugs according to treatments, drugs according to types and the major geographic regions of importance for this industry.
According to the type of treatment, the market can be further segmented as dry eye drugs, anti allergy drugs, retinal drugs and anti-glaucoma drugs. Amongst these, the segment of anti-glaucoma drugs currently has the major shares of demand and is also expected to observe market growth at the fastest pace in the coming years.
Regionally active markets
The US, as well as the overall region of North America, represents the largest market for the ophthalmic drugs industry.


Asia, as for many other industries, represents one of the major markets for this industry in the near future. The huge base of population in Asian countries such as China and India, a large share of which is getting old, is the major reason behind the enormous growth potential provided by this region for the ophthalmic drugs industry.
Developed regions such as North America and Western Europe also represent major growth opportunities for the region, owing to the rising government efforts for preventing blindness in the aging population.
Major ophthalmic companies from around the world are widening their focus on combination drugs - medications that involve the use of two or more medicines for retinal disorders. Combination drugs have the benefit of going well as first line treatment options for patients with high intraocular pressure. Combination drugs also have advantages over traditional medicines such as reduced need for drug application, improved efficacy and patient compliance.
Presently, the global ophthalmic drugs market is experiencing good growth, albeit it remains constrained due to the lack of new formulas in the market. The Businesses that have the capability of entering new horizons by choosing the path of combination medicines have the capability of significant growth in the future..